Rima Dardik Selected Research

Thrombocytopenia (Thrombopenia)

2/2013

Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rima Dardik Research Topics

Disease

12	Hemorrhage 11/2023 - 05/2002
6	Hemophilia A (Haemophilia) 07/2023 - 03/2019
4	Thrombosis (Thrombus) 12/2018 - 06/2002
3	von Willebrand Diseases (von Willebrand's Disease) 11/2023 - 01/2021
3	Choroidal Neovascularization 01/2019 - 12/2010
2	Wounds and Injuries (Trauma) 01/2022 - 03/2010
2	Neonatal Alloimmune Thrombocytopenia 01/2021 - 02/2013
2	Thrombophilia 01/2021 - 06/2002
2	Inflammation (Inflammations) 01/2017 - 01/2016
2	Rupture 01/2016 - 10/2012
2	Factor XI Deficiency (Hemophilia C) 08/2015 - 06/2003
2	Glaucoma 08/2007 - 06/2006
1	Epistaxis (Nosebleed) 11/2023
1	Disease Susceptibility (Diathesis) 11/2023
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 11/2023
1	Hemarthrosis 01/2021
1	Joint Diseases (Joint Disease) 01/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Type 3 von Willebrand Disease 01/2021
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 03/2019
1	Hypersensitivity (Allergy) 12/2018
1	Hemophilia B (Haemophilia B) 12/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2017
1	Pathologic Neovascularization 01/2016
1	Thrombasthenia (Glanzmann Thrombasthenia) 05/2014
1	Systemic Scleroderma (Systemic Sclerosis) 01/2014
1	Thrombocytopenia (Thrombopenia) 02/2013
1	Atherosclerotic Plaque (Atheroma) 10/2012
1	Atherosclerosis 10/2012
1	Intracranial Embolism 10/2012
1	Pathologic Constriction (Stenosis) 10/2012
1	Factor VII Deficiency (Hypoproconvertinemia) 07/2012
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2011
1	Hypoxia (Hypoxemia) 12/2010
1	Retinal Vein Occlusion 09/2006
1	Factor XIII Deficiency 03/2006
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2004
1	Genetic Predisposition to Disease (Genetic Predisposition) 06/2002

Drug/Important Bio-Agent (IBA)

4	Thrombin FDA Link 11/2023 - 08/2015
4	Factor VIII (Coagulation Factor VIII)IBA 07/2023 - 03/2019
3	Hemostatics (Antihemorrhagics)IBA 11/2023 - 01/2022
3	Glycoproteins (Glycoprotein)IBA 05/2014 - 01/2004
3	Platelet Membrane GlycoproteinsIBA 09/2006 - 06/2002
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2022 - 06/2003
2	Factor VII (Proconvertin)IBA 05/2021 - 07/2012
2	Protein CIBA 01/2021 - 01/2019
2	AntibodiesIBA 01/2021 - 08/2011
2	IntegrinsIBA 01/2021 - 02/2013
2	Retinal Pigments (Pigments, Visual)IBA 01/2016 - 12/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010 - 03/2010
1	Blood Coagulation Factors (Coagulation Factor)IBA 11/2023
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2022
1	Tranexamic Acid (AMCA)FDA Link 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	marstacimabIBA 01/2022
1	Vitamin K FDA Link 01/2022
1	emicizumabIBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2019
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 12/2018
1	prothrombin complex concentrates (PPSB)IBA 12/2018
1	CytokinesIBA 01/2017
1	TelluriumIBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 01/2016
1	AutoantibodiesIBA 05/2014
1	Zoledronic Acid (Zometa)FDA Link 01/2014
1	Diphosphonates (Bisphosphonates)IBA 01/2014
1	IsoantibodiesIBA 02/2013
1	HLA-DRB3 Chains (HLA DRB3)IBA 02/2013
1	HLA-DR Antigens (HLA-DR)IBA 02/2013
1	HLA-DRB4 Chains (HLA DRB4)IBA 02/2013
1	AntigensIBA 02/2013
1	Plasminogen InactivatorsIBA 10/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2012
1	LeptinIBA 10/2012
1	recombinant FVIIa (rFVIIa)FDA Link 07/2012
1	Phospholipids (Phosphatides)FDA LinkGeneric 08/2011
1	Peptides (Polypeptides)IBA 08/2011
1	Thromboplastin (Tissue Factor)IBA 08/2011
1	CopperIBA 03/2010
1	SilverIBA 03/2010
1	Hypoxia-Inducible Factor 1IBA 03/2010
1	OxidesIBA 03/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2010
1	CaspasesIBA 08/2007
1	Phosphotransferases (Kinase)IBA 08/2007
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 08/2007
1	Integrin alpha2IBA 09/2006
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 09/2006
1	Messenger RNA (mRNA)IBA 06/2006
1	Factor XIII (Coagulation Factor XIII)IBA 03/2006
1	Prothrombin (Factor II)IBA 06/2002
1	Genetic Markers (Genetic Marker)IBA 06/2002

Therapy/Procedure

5	Therapeutics 01/2023 - 07/2012
2	Operative Surgical Procedures 11/2023 - 01/2022
1	Critical Care (Surgical Intensive Care) 03/2019
1	Minor Surgical Procedures (Minor Surgery) 12/2018
1	Aftercare (After-Treatment) 01/2014
1	Carotid Endarterectomy 10/2012
1	Lasers (Laser) 08/2007
1	Light Coagulation 08/2007